Regulation of Secondary Antigen-Specific CD8+ T-Cell Responses by Natural Killer T Cells

The physiologic function of natural killer T (NKT) cells in adaptive immunity remains largely unknown because most studies have used NKT cell agonists. In the present study, the role of NKT cells during the secondary effector phase was investigated separately from the primary immunization phase via...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer research (Chicago, Ill.) Ill.), 2009-05, Vol.69 (10), p.4301-4308
Hauptverfasser: CHANGWAN HONG, LEE, Hyunji, PARK, Yoon-Kyung, SHIN, Junghoon, SUNDO JUNG, KIM, Hoyeon, HONG, Seokmann, PARK, Se-Ho
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4308
container_issue 10
container_start_page 4301
container_title Cancer research (Chicago, Ill.)
container_volume 69
creator CHANGWAN HONG
LEE, Hyunji
PARK, Yoon-Kyung
SHIN, Junghoon
SUNDO JUNG
KIM, Hoyeon
HONG, Seokmann
PARK, Se-Ho
description The physiologic function of natural killer T (NKT) cells in adaptive immunity remains largely unknown because most studies have used NKT cell agonists. In the present study, the role of NKT cells during the secondary effector phase was investigated separately from the primary immunization phase via adoptive transfer of differentiated effector T cells into naive recipients. We found that secondary antitumor CD8(+) T-cell responses were optimal when NKT cells were present. Tumor-specific CD8(+) effector T cells responded less strongly to tumor cell challenge in NKT cell-deficient recipients than in recipients with intact NKT cells. NKT cell-mediated enhancement of the secondary antitumor CD8(+) T-cell response was concurrent with increased number and activity of tumor-specific CD8(+) T cells. These findings provide the first demonstration of a direct role for NKT cells in the regulation of antigen-specific secondary T-cell responses without the use of exogenous NKT cell agonists such as alpha-galactosylceramide (alpha-GalCer). Furthermore, forced activation of NKT cells with alpha-GalCer during the secondary immune response in suboptimally immunized animals enhanced otherwise poor tumor rejection responses. Taken together, our findings strongly emphasize the importance of NKT cells in secondary CD8(+) T-cell immune responses.
doi_str_mv 10.1158/0008-5472.CAN-08-1721
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67247808</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67247808</sourcerecordid><originalsourceid>FETCH-LOGICAL-c418t-16133c0967e114e1760970acee38a4effb1701c4a51bbd32886b94df7572f2863</originalsourceid><addsrcrecordid>eNpFkMlOwzAQQC0EgrJ8AsgXuKAUj2PH7rEKq6iKVIrEzXLccRWUJiVODvw9jqjKaWakN9sj5BLYGEDqO8aYTqRQfJxP50nMQXE4ICOQqU6UEPKQjPbMCTkN4SuWEpg8JicwEQyETEfkc4HrvrJd2dS08fQdXVOvbPtDp3VXrrFO3rfoSl86mt_rW7pMcqwqusCwbeqAgRY_dG67vrUVfS2rClu6pAMSzsmRt1XAi108Ix-PD8v8OZm9Pb3k01niBOgugQzS1LFJphBAIKiMTRSzDjHVVqD3BSgGTlgJRbFKudZZMRErr6TinussPSM3f3O3bfPdY-jMpgwuXmBrbPpgMsWF0kxHUP6Brm1CaNGbbVtu4qsGmBmUmkGXGXSZqNTEfFAa-652C_pig6v_rp3DCFzvABucrXxra1eGPcdBKc25SH8BnFt8yw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67247808</pqid></control><display><type>article</type><title>Regulation of Secondary Antigen-Specific CD8+ T-Cell Responses by Natural Killer T Cells</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>American Association for Cancer Research</source><creator>CHANGWAN HONG ; LEE, Hyunji ; PARK, Yoon-Kyung ; SHIN, Junghoon ; SUNDO JUNG ; KIM, Hoyeon ; HONG, Seokmann ; PARK, Se-Ho</creator><creatorcontrib>CHANGWAN HONG ; LEE, Hyunji ; PARK, Yoon-Kyung ; SHIN, Junghoon ; SUNDO JUNG ; KIM, Hoyeon ; HONG, Seokmann ; PARK, Se-Ho</creatorcontrib><description>The physiologic function of natural killer T (NKT) cells in adaptive immunity remains largely unknown because most studies have used NKT cell agonists. In the present study, the role of NKT cells during the secondary effector phase was investigated separately from the primary immunization phase via adoptive transfer of differentiated effector T cells into naive recipients. We found that secondary antitumor CD8(+) T-cell responses were optimal when NKT cells were present. Tumor-specific CD8(+) effector T cells responded less strongly to tumor cell challenge in NKT cell-deficient recipients than in recipients with intact NKT cells. NKT cell-mediated enhancement of the secondary antitumor CD8(+) T-cell response was concurrent with increased number and activity of tumor-specific CD8(+) T cells. These findings provide the first demonstration of a direct role for NKT cells in the regulation of antigen-specific secondary T-cell responses without the use of exogenous NKT cell agonists such as alpha-galactosylceramide (alpha-GalCer). Furthermore, forced activation of NKT cells with alpha-GalCer during the secondary immune response in suboptimally immunized animals enhanced otherwise poor tumor rejection responses. Taken together, our findings strongly emphasize the importance of NKT cells in secondary CD8(+) T-cell immune responses.</description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>DOI: 10.1158/0008-5472.CAN-08-1721</identifier><identifier>PMID: 19401453</identifier><identifier>CODEN: CNREA8</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Adoptive Transfer ; Animals ; Antigens, CD1d - genetics ; Antigens, CD1d - immunology ; Antineoplastic agents ; Biological and medical sciences ; CD8-Positive T-Lymphocytes - immunology ; Cytotoxicity, Immunologic - immunology ; Flow Cytometry ; Immunity, Innate ; Killer Cells, Natural - immunology ; Lymphocyte Activation ; Medical sciences ; Melanoma, Experimental - immunology ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Mice, Transgenic ; Ovalbumin - genetics ; Ovalbumin - immunology ; Pharmacology. Drug treatments ; Receptors, Antigen, T-Cell - genetics ; Tumors</subject><ispartof>Cancer research (Chicago, Ill.), 2009-05, Vol.69 (10), p.4301-4308</ispartof><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c418t-16133c0967e114e1760970acee38a4effb1701c4a51bbd32886b94df7572f2863</citedby><cites>FETCH-LOGICAL-c418t-16133c0967e114e1760970acee38a4effb1701c4a51bbd32886b94df7572f2863</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,3345,27911,27912</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21778224$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19401453$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>CHANGWAN HONG</creatorcontrib><creatorcontrib>LEE, Hyunji</creatorcontrib><creatorcontrib>PARK, Yoon-Kyung</creatorcontrib><creatorcontrib>SHIN, Junghoon</creatorcontrib><creatorcontrib>SUNDO JUNG</creatorcontrib><creatorcontrib>KIM, Hoyeon</creatorcontrib><creatorcontrib>HONG, Seokmann</creatorcontrib><creatorcontrib>PARK, Se-Ho</creatorcontrib><title>Regulation of Secondary Antigen-Specific CD8+ T-Cell Responses by Natural Killer T Cells</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>The physiologic function of natural killer T (NKT) cells in adaptive immunity remains largely unknown because most studies have used NKT cell agonists. In the present study, the role of NKT cells during the secondary effector phase was investigated separately from the primary immunization phase via adoptive transfer of differentiated effector T cells into naive recipients. We found that secondary antitumor CD8(+) T-cell responses were optimal when NKT cells were present. Tumor-specific CD8(+) effector T cells responded less strongly to tumor cell challenge in NKT cell-deficient recipients than in recipients with intact NKT cells. NKT cell-mediated enhancement of the secondary antitumor CD8(+) T-cell response was concurrent with increased number and activity of tumor-specific CD8(+) T cells. These findings provide the first demonstration of a direct role for NKT cells in the regulation of antigen-specific secondary T-cell responses without the use of exogenous NKT cell agonists such as alpha-galactosylceramide (alpha-GalCer). Furthermore, forced activation of NKT cells with alpha-GalCer during the secondary immune response in suboptimally immunized animals enhanced otherwise poor tumor rejection responses. Taken together, our findings strongly emphasize the importance of NKT cells in secondary CD8(+) T-cell immune responses.</description><subject>Adoptive Transfer</subject><subject>Animals</subject><subject>Antigens, CD1d - genetics</subject><subject>Antigens, CD1d - immunology</subject><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>CD8-Positive T-Lymphocytes - immunology</subject><subject>Cytotoxicity, Immunologic - immunology</subject><subject>Flow Cytometry</subject><subject>Immunity, Innate</subject><subject>Killer Cells, Natural - immunology</subject><subject>Lymphocyte Activation</subject><subject>Medical sciences</subject><subject>Melanoma, Experimental - immunology</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Mice, Transgenic</subject><subject>Ovalbumin - genetics</subject><subject>Ovalbumin - immunology</subject><subject>Pharmacology. Drug treatments</subject><subject>Receptors, Antigen, T-Cell - genetics</subject><subject>Tumors</subject><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkMlOwzAQQC0EgrJ8AsgXuKAUj2PH7rEKq6iKVIrEzXLccRWUJiVODvw9jqjKaWakN9sj5BLYGEDqO8aYTqRQfJxP50nMQXE4ICOQqU6UEPKQjPbMCTkN4SuWEpg8JicwEQyETEfkc4HrvrJd2dS08fQdXVOvbPtDp3VXrrFO3rfoSl86mt_rW7pMcqwqusCwbeqAgRY_dG67vrUVfS2rClu6pAMSzsmRt1XAi108Ix-PD8v8OZm9Pb3k01niBOgugQzS1LFJphBAIKiMTRSzDjHVVqD3BSgGTlgJRbFKudZZMRErr6TinussPSM3f3O3bfPdY-jMpgwuXmBrbPpgMsWF0kxHUP6Brm1CaNGbbVtu4qsGmBmUmkGXGXSZqNTEfFAa-652C_pig6v_rp3DCFzvABucrXxra1eGPcdBKc25SH8BnFt8yw</recordid><startdate>20090515</startdate><enddate>20090515</enddate><creator>CHANGWAN HONG</creator><creator>LEE, Hyunji</creator><creator>PARK, Yoon-Kyung</creator><creator>SHIN, Junghoon</creator><creator>SUNDO JUNG</creator><creator>KIM, Hoyeon</creator><creator>HONG, Seokmann</creator><creator>PARK, Se-Ho</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20090515</creationdate><title>Regulation of Secondary Antigen-Specific CD8+ T-Cell Responses by Natural Killer T Cells</title><author>CHANGWAN HONG ; LEE, Hyunji ; PARK, Yoon-Kyung ; SHIN, Junghoon ; SUNDO JUNG ; KIM, Hoyeon ; HONG, Seokmann ; PARK, Se-Ho</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c418t-16133c0967e114e1760970acee38a4effb1701c4a51bbd32886b94df7572f2863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adoptive Transfer</topic><topic>Animals</topic><topic>Antigens, CD1d - genetics</topic><topic>Antigens, CD1d - immunology</topic><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>CD8-Positive T-Lymphocytes - immunology</topic><topic>Cytotoxicity, Immunologic - immunology</topic><topic>Flow Cytometry</topic><topic>Immunity, Innate</topic><topic>Killer Cells, Natural - immunology</topic><topic>Lymphocyte Activation</topic><topic>Medical sciences</topic><topic>Melanoma, Experimental - immunology</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Mice, Transgenic</topic><topic>Ovalbumin - genetics</topic><topic>Ovalbumin - immunology</topic><topic>Pharmacology. Drug treatments</topic><topic>Receptors, Antigen, T-Cell - genetics</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>CHANGWAN HONG</creatorcontrib><creatorcontrib>LEE, Hyunji</creatorcontrib><creatorcontrib>PARK, Yoon-Kyung</creatorcontrib><creatorcontrib>SHIN, Junghoon</creatorcontrib><creatorcontrib>SUNDO JUNG</creatorcontrib><creatorcontrib>KIM, Hoyeon</creatorcontrib><creatorcontrib>HONG, Seokmann</creatorcontrib><creatorcontrib>PARK, Se-Ho</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>CHANGWAN HONG</au><au>LEE, Hyunji</au><au>PARK, Yoon-Kyung</au><au>SHIN, Junghoon</au><au>SUNDO JUNG</au><au>KIM, Hoyeon</au><au>HONG, Seokmann</au><au>PARK, Se-Ho</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Regulation of Secondary Antigen-Specific CD8+ T-Cell Responses by Natural Killer T Cells</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>2009-05-15</date><risdate>2009</risdate><volume>69</volume><issue>10</issue><spage>4301</spage><epage>4308</epage><pages>4301-4308</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><coden>CNREA8</coden><abstract>The physiologic function of natural killer T (NKT) cells in adaptive immunity remains largely unknown because most studies have used NKT cell agonists. In the present study, the role of NKT cells during the secondary effector phase was investigated separately from the primary immunization phase via adoptive transfer of differentiated effector T cells into naive recipients. We found that secondary antitumor CD8(+) T-cell responses were optimal when NKT cells were present. Tumor-specific CD8(+) effector T cells responded less strongly to tumor cell challenge in NKT cell-deficient recipients than in recipients with intact NKT cells. NKT cell-mediated enhancement of the secondary antitumor CD8(+) T-cell response was concurrent with increased number and activity of tumor-specific CD8(+) T cells. These findings provide the first demonstration of a direct role for NKT cells in the regulation of antigen-specific secondary T-cell responses without the use of exogenous NKT cell agonists such as alpha-galactosylceramide (alpha-GalCer). Furthermore, forced activation of NKT cells with alpha-GalCer during the secondary immune response in suboptimally immunized animals enhanced otherwise poor tumor rejection responses. Taken together, our findings strongly emphasize the importance of NKT cells in secondary CD8(+) T-cell immune responses.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>19401453</pmid><doi>10.1158/0008-5472.CAN-08-1721</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0008-5472
ispartof Cancer research (Chicago, Ill.), 2009-05, Vol.69 (10), p.4301-4308
issn 0008-5472
1538-7445
language eng
recordid cdi_proquest_miscellaneous_67247808
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; American Association for Cancer Research
subjects Adoptive Transfer
Animals
Antigens, CD1d - genetics
Antigens, CD1d - immunology
Antineoplastic agents
Biological and medical sciences
CD8-Positive T-Lymphocytes - immunology
Cytotoxicity, Immunologic - immunology
Flow Cytometry
Immunity, Innate
Killer Cells, Natural - immunology
Lymphocyte Activation
Medical sciences
Melanoma, Experimental - immunology
Mice
Mice, Inbred C57BL
Mice, Knockout
Mice, Transgenic
Ovalbumin - genetics
Ovalbumin - immunology
Pharmacology. Drug treatments
Receptors, Antigen, T-Cell - genetics
Tumors
title Regulation of Secondary Antigen-Specific CD8+ T-Cell Responses by Natural Killer T Cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T11%3A05%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Regulation%20of%20Secondary%20Antigen-Specific%20CD8+%20T-Cell%20Responses%20by%20Natural%20Killer%20T%20Cells&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=CHANGWAN%20HONG&rft.date=2009-05-15&rft.volume=69&rft.issue=10&rft.spage=4301&rft.epage=4308&rft.pages=4301-4308&rft.issn=0008-5472&rft.eissn=1538-7445&rft.coden=CNREA8&rft_id=info:doi/10.1158/0008-5472.CAN-08-1721&rft_dat=%3Cproquest_cross%3E67247808%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67247808&rft_id=info:pmid/19401453&rfr_iscdi=true